The HCPLive spondyloarthritis page is a resource for medical news and expert insights on spondylitis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for autoimmune disease, and more.
April 2nd 2024
Exercise was beneficial in functional status for both patients with RA and spondyloarthritis.
Are Older TNF Inhibitors More Effective at Treating Psoriatic Arthritis Than Newer Drugs?
A meta-study of randomized controlled trials indicates that older TNF-inhibitors such as etanercept or infliximab treat psoriatic arthritis more effectively than newer TNF-inhibitors.
Less Frequent Biologics Dosing Is Safe and Effective in Patients with Psoriatic Arthritis
Longer intervals between injections of anti-TNF drugs in patients with psoriatic arthritis is "safe, effective, cost-effective, and facilitates patient compliance," according to researchers.
Psoriatic Arthritis Does Not Increase Risk of Poor Outcomes Following Hip Replacement
A study of patients undergoing total hip arthroplasty found that patients with psoriatic arthritis face no greater risk of poor outcomes than patients who get hip replacements because of osteoarthritis.
Studies: Exercise and Sleep Are Key in Ankylosing Spondylitis
A recent study suggests that patients with ankylosing spondylitis (AS) have a higher incidence of obstructive sleep apnea syndrome that increases with the severity of cervical vertebral involvement. A separate study published on the same day suggests that specific exercise regimens may be beneficial for patients with AS.
RAPID3 Shown to Be an Effective Assessment Tool for Patients with Psoriatic Arthritis
New research suggests that a 10-second self assessment might provide nearly as much information about psoriatic arthritis case progression as complex tests that generally require either require laboratory results or formal joint-by-joint evaluation.
Patients with Psoriatic Arthritis at Higher Risk for Uveitis
Researchers found that not only are patients with psoriasis or psoriatic arthritis at higher risk for uveitis, the association is bidirectional: patients with uveitis are at increased risk for psoriasis and psoriatic arthritis
10-Year Follow-up Study on Safety and Efficacy of Adalimumab
Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.
IL-Targeted Biologics for Treatment of Psoriasis Show Promising Efficacy
A recent review looked at the immunopathogenesis of psoriasis, identified key mediators of psoriatic plaques that are being targeted by new and emerging biologic therapies, and highlighted the latest efficacy and safety data from trials of these new agents.
Treatment with Biologics Improves Measures of Work Disability in Patients with Psoriatic Arthritis
Treatment with anti-TNF drugs and DMARDs is associated with clinically significant improvement measures of work disability such as presenteeism and productivity loss in patients with psoriatic arthritis.
Retrospective Study Confirms Need for LTBI Screening Prior to Starting Biologic Therapy
Inflammatory chronic diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis bring many treatment challenges. Among them is the fact that biologic therapies for these diseases-particularly anti-TNF agents-while effective, can themselves bring reactivation of a latent tuberculosis infection.
IL-17A Inhibitor Significantly Improved Signs and Symptoms of Psoriatic Arthritis in Year-Long Study
Researchers announced a phase 3 trial assessing secukinumab for the treatment of psoriatic arthritis met its primary endpoint (ACR 20 at week 24), possibly putting the drug on the fast track to approval.